These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16243496

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H, Bodmeier R.
    Int J Pharm; 2007 Mar 06; 332(1-2):107-14. PubMed ID: 17084049
    [Abstract] [Full Text] [Related]

  • 3. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems.
    Luan X, Bodmeier R.
    J Control Release; 2006 Jan 10; 110(2):266-272. PubMed ID: 16300851
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modification of the tri-phasic drug release pattern of leuprolide acetate-loaded poly(lactide-co-glycolide) microparticles.
    Luan X, Bodmeier R.
    Eur J Pharm Biopharm; 2006 Jun 10; 63(2):205-14. PubMed ID: 16621485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems.
    Dong WY, Körber M, López Esguerra V, Bodmeier R.
    J Control Release; 2006 Oct 10; 115(2):158-67. PubMed ID: 16963145
    [Abstract] [Full Text] [Related]

  • 8. Leuprolide Acetate Release Study from γ-Irradiated PLGA-based In Situ Forming System.
    Shapourgan M, Mobedi H, Sheikh N, Behnamghader A, Mashak A.
    Curr Drug Deliv; 2017 Oct 10; 14(8):1170-1177. PubMed ID: 28530536
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
    Duvvuri S, Janoria KG, Pal D, Mitra AK.
    J Ocul Pharmacol Ther; 2007 Jun 10; 23(3):264-74. PubMed ID: 17593010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ivermectin-loaded microparticles for parenteral sustained release: in vitro characterization and effect of some formulation variables.
    Camargo JA, Sapin A, Daloz D, Maincent P.
    J Microencapsul; 2010 Jun 10; 27(7):609-17. PubMed ID: 20695833
    [Abstract] [Full Text] [Related]

  • 16. In vivo evaluation of solid lipid microparticles and hybrid polymer-lipid microparticles for sustained delivery of leuprolide.
    Wu C, Luo X, Baldursdottir SG, Yang M, Sun X, Mu H.
    Eur J Pharm Biopharm; 2019 Sep 10; 142():315-321. PubMed ID: 31299277
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization.
    Camargo JA, Sapin A, Nouvel C, Daloz D, Leonard M, Bonneaux F, Six JL, Maincent P.
    Drug Dev Ind Pharm; 2013 Jan 10; 39(1):146-55. PubMed ID: 22397675
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
    Mao S, Shi Y, Li L, Xu J, Schaper A, Kissel T.
    Eur J Pharm Biopharm; 2008 Feb 10; 68(2):214-23. PubMed ID: 17651954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.